Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis

10.1371/journal.pone.0090176

Saved in:

Bibliographic Details
Main Authors:	Ann Chai, L.Y., Kullberg, B.J., Earnest, A., Johnson, E.M., Teerenstra, S., Vonk, A.G., Schlamm, H.T., Herbrecht, R., Netea, M.G., Troke, P.F.
Other Authors:	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/110345
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-110345
record_format	dspace
spelling	sg-nus-scholar.10635-1103452023-10-30T23:04:26Z Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis Ann Chai, L.Y. Kullberg, B.J. Earnest, A. Johnson, E.M. Teerenstra, S. Vonk, A.G. Schlamm, H.T. Herbrecht, R. Netea, M.G. Troke, P.F. DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE 10.1371/journal.pone.0090176 PLoS ONE 9 2 - POLNC 2014-11-26T08:31:19Z 2014-11-26T08:31:19Z 2014-02-28 Article Ann Chai, L.Y., Kullberg, B.J., Earnest, A., Johnson, E.M., Teerenstra, S., Vonk, A.G., Schlamm, H.T., Herbrecht, R., Netea, M.G., Troke, P.F. (2014-02-28). Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis. PLoS ONE 9 (2) : -. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0090176 19326203 http://scholarbank.nus.edu.sg/handle/10635/110345 000332396200142 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
description	10.1371/journal.pone.0090176
author2	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
author_facet	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE Ann Chai, L.Y. Kullberg, B.J. Earnest, A. Johnson, E.M. Teerenstra, S. Vonk, A.G. Schlamm, H.T. Herbrecht, R. Netea, M.G. Troke, P.F.
format	Article
author	Ann Chai, L.Y. Kullberg, B.J. Earnest, A. Johnson, E.M. Teerenstra, S. Vonk, A.G. Schlamm, H.T. Herbrecht, R. Netea, M.G. Troke, P.F.
spellingShingle	Ann Chai, L.Y. Kullberg, B.J. Earnest, A. Johnson, E.M. Teerenstra, S. Vonk, A.G. Schlamm, H.T. Herbrecht, R. Netea, M.G. Troke, P.F. Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis
author_sort	Ann Chai, L.Y.
title	Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis
title_short	Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis
title_full	Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis
title_fullStr	Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis
title_full_unstemmed	Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis
title_sort	voriconazole or amphotericin b as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis
publishDate	2014
url	http://scholarbank.nus.edu.sg/handle/10635/110345
_version_	1781788846245019648

Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis

Similar Items